Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
|
|
- Mercy Griffin
- 5 years ago
- Views:
Transcription
1 Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution 1mg/mL Capsules: 1.5mg 3mg 4.5mg 6mg Patch: 4.6mg/24 Hour 9.5mg/24 Hour 13.3mg/24 Hour 2mg/mL Alzheimer s Disease Dementia with Lewy Bodies Parkinson s Disease Dementia Vascular Dementia Class Adverse Drug Reactions (ADRs) Nausea Vomiting Diarrhea Weight Loss GI Bleeds Insomnia (9%) Weight Loss (8%) Nightmares (3%) Drug-Specific ADRs & Clinical Pearls Bradycardia/Syncope (2%) QT Prolongation (1%) Starting dose 5mg QD x 4 weeks, then QD, if tolerated titrate to 23mg. Due to risk of syncope dose at bedtime. If abnormal/bothersome dreams or insomnia may switch to daytime dosing. Most likely in drug class to have GI effects. Nausea (30%), Vomiting (15%) GI effects likely with oral formulation. GI effects unlikely with patch formulation. Tremor (17%), Dizziness (7%) Take oral dose with food. Starting dose 1.5mg BID x 4 weeks, titrating to highest tolerated dose. Starting dose for Patch 4.6mg QD x 4 weeks, titrating to highest tolerated dose. 9.5mg Patch = 6mg PO BID. Approved for Dementia associated with Parkinson s Disease.
2 Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Razadyne (galantamine) Namenda (memantine) BID 4mg 8mg 12mg 4mg/mL ER Capsules: QD 8mg 16mg 24mg QD or BID 5mg /5mL ER Capsules: QD 7mg 14mg 21mg 28mg **See Previous Page Alzheimer s Disease Vascular Dementia Class Adverse Drug Reactions (ADRs) **See Previous Page Drug-Specific ADRs & Clinical Pearls Anorexia/Weight Loss (9%) Dizziness (9%) Headache (8%) Abdominal Pain (5%) Take with food to minimize GI effects. Starting dose 4mg BID x 4 weeks, titrating to highest tolerated dose. Starting dose for Extended Release formulation 8mg QD x 4 weeks, titrating to highest tolerated dose. Originally named Reminyl Dizziness (7%) Confusion (6%) Headache (6%) Constipation (5%) Give with an AChEI to blunt ADRs and augment clinical benefits. Starting dose 5mg QD x 7 days, then 5mg BID x 7 days, then 5mg QAM & QHS x 7 days, then BID. Starting dose for Extended Release 7mg QD x 7 days, then 14mg QD x 7 days, then 21mg QD x 7 days, then 28mg QD. Renal dosing for CrCL < 30mL/min: 5mg BID, QD, XR 14mg QD. Europe has ALWAYS dosed 20mg QD. Do not mix solution with any other liquid.
3 Medication Dosage Indication for Use Celexa (citalopram) Lexapro (escitalopram) 20mg 40mg /5mL 5mg 20mg 5mg/5mL Anti-Depressants Selective Serotonin Reuptake Inhibitors (SSRIs) Generalized Anxiety Disorder (GAD) Obsessive- Compulsive Disorder (OCD) Panic Disorder Post-Traumatic Stress Disorder (PTSD) Social Anxiety Disorder Class Adverse Drug Reactions (ADRs) Nausea Vomiting Headache Sleep Disturbances Agitation Sexual Dysfunction Tremor Dizziness Constipation Weight Changes Gastrointestinal (GI) Bleeds Drug-Specific ADRs & Clinical Pearls QT Prolongation (dose dependent) Initial dose 20mg QD and maximum dose 40mg QD. Adults > 60 years maximum dose of 20mg QD due to QT prolongation & development of life-threatening arrhythmias. Well tolerated, minimal side-effects, low incidence of drug interactions. Least likely SSRI to be discontinued due to ADRs. Initial dose QD and maximum dose 20mg QD. Geriatric maximum dose is QD. Both 10 and 20mg dose are EQUALLY effective therapy. Isomer of Citalopram Meta-analysis of over 2000 adults found Escitalopram to be significantly more effective than citalopram in overall treatment effect (response & remission rate). Duplicate analysis could not confirm above analysis. Most likely SSRI to have the quickest onset of action. Paxil (paroxetine) 20mg 30mg 40mg CR 12.5mg* 25mg* 37.5mg* /5mL Somnolence (23%), Dry mouth (18%) Headache (18%), Constipation (14%) Sexual Dysfunction (10%) Typically avoided in the elderly d/t anticholinergic activity. Best SSRI for sexual aggression. Immediate Release: Initial dose 20mg QD (Geriatric ) and maximum dose 50mg QD (Geriatric 40mg). Controlled Release: Initial dose 25mg QD (Geriatric 12.5mg) and maximum dose 62.5mg QD (Geriatric 50mg). Anxiety responds best to 20mg QD and higher doses do not appear to provide additional benefit.
4 Medication Dosage Indication for Use Prozac (fluoxetine) Zoloft (sertraline) 20mg 40mg DR 90mg* 20mg/5mL 25mg 50mg 100mg 20mg/mL Anti-Depressants Selective Serotonin Reuptake Inhibitors (SSRIs) **See Previous Page Class Adverse Drug Reactions (ADRs) **See Previous Page Drug-Specific ADRs & Clinical Pearls Headache (21%), Insomnia (19%) Anxiety (10%), Weight Loss (7%) First SSRI to be marketed in the US. Half-life after chronic administration is 4 to 6 days. Long half-life of Fluoxetine allow for once weekly administration in some patients. Initial dose 20mg QD and maximum dose 80mg QD. Delayed Release: Initial dose 90mg QD once weekly, beginning 7 days after the last 20mg daily dose. Anxiety responds well to 20mg QD most studied dose. Bulimia Nervosa dose found to be 60mg QD in clinical studies and smaller doses have not been found effective. May be beneficial treatment for depression or panic disorder in patients suffering from obesity. Headache (25%), Nausea (25%) Insomnia (21%), Diarrhea (20%) Initial dose 50mg QD and maximum dose 200mg QD. Anxiety Disorder Initial dose 25mg QD, after one week, increase to 50mg QD. If necessary maximum dose 200mg QD. Oral solution must be further diluted in an acceptable liquid immediately before administration. Caution recommended for persons with a latex sensitivity because the dropper dispenser contains dry natural rubber.
5 Anti-Depressants Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Medication Dosage Indication for Use Drug-Specific ADRs & Clinical Pearls Cymbalta (duloxetine) DR Capsules: 20 mg 30 mg 60 mg Diabetic Neuropathy Fibromyalgia Generalized Anxiety Disorder Musculoskeletal Pain Osteoarthritis Off- Urinary Incontinence Nausea (23%), Headache (14%), Dry Mouth (13%), Somnolence/Fatigue (10%) Insomnia (9%), Hyperhidrosis (6%) Initially 20mg BID or 30mg QD titrated to 60mg QD. Maximum dose 120mg QD. Dividing the dose may increase tolerability (30mg BID). Doses greater than 60mg QD have not shown additional benefit but have increased rates of ADRs. CrCL < 30mL/min - therapy NOT recommended. Avoid use in patient with chronic liver disease or cirrhosis. First drug with FDA approval for Diabetic Peripheral Neuropathy. Effexor (venlafaxine) 25 mg 37.5 mg 50 mg 75 mg 100 mg ER Capsules: 37.5 mg 75 mg 150 mg ER 37.5 mg* 75 mg* 150 mg* 225 mg* Generalized Anxiety Disorder (GAD) Panic Disorder Social Anxiety Disorder Off- Diabetic Neuropathy Fibromyalgia Migraine Prophylaxis Obsessive- Compulsive Disorder (OCD) Nausea (30%), Insomnia (18%), Dizziness (16%), Somnolence (15%) Dry Mouth (15%), Hyperhidrosis (11%), Anorexia (10%) Nickname Side-Effexor Administer with food to minimize GI effects. Immediate Release: Initial dose 75mg QD given in 2 to 3 divided doses. Maximum dose for outpatients 225mg QD (2-3 divided doses) and inpatients 375mg QD (3 divided doses). Extended Release: Initial dose 75mg QD (37.5mg can be given to increase tolerability for 3-4 days prior to increasing dose) and maximum dose 225mg QD. First antidepressant to receive FDA approval for the treatment of Generalized Anxiety Disorder (GAD). Anxiety Disorders seem to respond well to 75mg QD and there is little clinical benefit that higher doses yield additional benefit. Doses < 150mg QD = SSRI therapy. Doses > 150mg QD = SNRI therapy. For moderate hepatic impairment reduce dose by 50% For moderate to severe renal function reduce dose by 25 to 50%
6 Anti-Depressants Miscellaneous Medication Dosage Indication for Use Drug-Specific ADRs & Clinical Pearls Desyrel (trazodone) Remeron (mirtazapine) 50 mg 100 mg 150 mg 300 mg ER 150mg* 300mg* 7.5 mg 15 mg 30 mg 45 mg ODT 15 mg 30 mg 45 mg Off- Ethanol Dependence Generalized Anxiety Disorder (GAD) Insomnia Panic Disorder Off- Benign Familial Tremor Pruritus Tremor Drowsiness (41%), Dry Mouth (34%), Dizziness/Lightheadedness (28%) Headache (20%), Blurred Vision (15%), Nausea/Vomiting (13%) : Initial dose 150mg QD in divided doses and maximum dose 400mg QD (outpatients) and 600mg QD (inpatients) Insomnia: Initial dose 100mg (range 25 to 100mg) at bedtime. Possesses some similarities of action to other antidepressant drugs, however, also has some action as an anxiolytic. Sedative effect believed to be produced by modest histamine blockage. May improve sleep patterns associated with depression. Peak concentration is achieved 1 hours after dosing in the fasting state and 2 hours after dosing with food. Response to therapy typically seen by the end of the second week of therapy. Somnolence (54%), Dry Mouth (25%), Increased Appetite (17%), Constipation (13%), Weight Gain (12%) Initial dose 15mg QHS and maximum dose 45mg QHS. Possesses an anxiolytic effect that may be useful in depressed patients who have a coexisting anxiety disorder. Potent antagonist of histamine receptors which may explain it prominent sedative effects. May improve sleep patterns associated with depression. Faster onset of antidepressant efficacy, with maximal effect within 2 to 4 weeks of adequate dosage selection. Avoid abrupt discontinuation withdrawal symptoms have been reported.
7 Anti-Depressants Miscellaneous Medication Dosage Indication for Use Drug-Specific ADRs & Clinical Pearls Wellbutrin (bupropion) TID 75 mg 100 mg SR BID 100 mg* 150 mg* 200 mg* ER QD 150 mg* 300 mg* Nicotine Withdrawal Seasonal Affective Disorder (SAD) Off- Attention-Deficit Hyperactivity Disorder (ADHD) Diabetic Neuropathy Neuropathic Pain Postherpetic Neuralgia Agitation (32%), Dry Mouth (28%), Headache (26%), Constipation (26%), Hyperhidrosis (22%), Nausea/Vomiting (23%), Dizziness (23%), Tremor (21%), Sedation (20%), Insomnia (19%), Blurred Vision (15%), Tachycardia (11%) Immediate Release: 100mg BID titrated to 100mg TID. No single dose should exceed 150mg. Maximum dose 450mg daily. Sustained Release: 150mg QD titrated to 150mg BID. Titration can continue to 200mg BID but at least 8 hours apart. No single dose should exceed 200mg. Maximum dose 400mg daily. Extended Release: 150mg QD and titrate to target dose 300mg daily with maximum dose of 450mg daily. Hepatic & Renal Impairment requires dose reductions. The onset of antidepressant effects takes 1 to 3 weeks, maximal effects may not be noted for 4 weeks. First prescription product approved for patients with a history of Seasonal Affective Disorder. Greater potential for causing seizures compared to other antidepressants. Drug removed from the market from 1985 to 1989 to further evaluate link to Seizures. To avoid or limit the risk of insomnia, do not administer doses at bedtime.
8 Mood Stabilizers Medication Dosage Indication for Use Drug-Specific ADRs & Clinical Pearls Depakote (valproic acid) Capsules: 125mg DR 125mg* 250mg* 500mg* ER 250mg* 500mg* Bipolar Disorder Migraine Prophylaxis Seizures Unlabeled: Agitation Attention-Deficit Hyperactivity Disorder (ADHD) Hiccups Nausea (31%), Somnolence (17%), Dyspepsia (13%), Dizziness (12%), Diarrhea (12%), Vomiting (11%), Abdominal Pain (9%), Tremor (9%) Dose: Start Low, Go Slow, But Go. Actual guidance lacking. Meta-analysis of available data indicate ineffectiveness in treating agitation among patients with dementia and that therapy is associated with an unacceptable rate of adverse effects. Risk of death seen with Valproic Acid was similar to antipsychotics (VA study of 91,000 American Veterans over the age of 65 years of age.) Administer with food to minimize GI irritation. CBC (thrombocytopenia), LFTs, and Ammonia should be monitored. Serum concentration evaluated to rule out potential toxicity not to evaluate efficacy of therapy for behavioral symptoms.
Quick Guide to Common Antidepressants-Adults
Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa
More informationCommon Antidepressant Medications for Adults
(and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationANTI-DEPRESSANT MEDICATIONS
ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationBRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.
BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation
More informationThe Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationPsychotropic Strategies Handout Package
Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationOptimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE
Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Chan-Hyung Kim, MD Severance Mental Health Hospital Institute of Behavioral Science in Medicine Diagnostic Criteria Pyramid Etiologic Pathophysiologic
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationPartners in Care Quick Reference Cards
Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationPsychiatric Treatment of the Concussed Athlete
Psychiatric Treatment of the Concussed Athlete Eastern Athletic Trainers Association January 11 th, 2015 Alexander S. Strauss, MD Centra, P.C. E-MAIL: DRSTRAUSS@ALEXSTRAUSSMD.COM Evidence Mounts Linking
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationSUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Managing Depression in Older Adults Developed March 1, 2003 Revised September 21,
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationMedications, By Class, in TBI
Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal
More informationElavil (amitriptyline)
Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information
More informationDaniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School
Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical
More informationTreatment of Depression in the Primary Care Office
Treatment of Depression in the Primary Care Office Paul E.A. Glaser, MD, PhD Departments of Psychiatry, Pediatrics and Anatomy & Neurobiology University of Kentucky November 5, 2010 Disclosures of Potential
More informationNorpramin (desipramine)
Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)
More informationManagement of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*
Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationManagement Of Depression And Anxiety
Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate
More informationPart 2: Pain and Symptom Management Depression
Guidelines & Protocols Advisory Committee Part 2: Pain and Symptom Management Depression Effective Date: February 22, 2017 Key Recommendations Before diagnosing and treating major depressive disorder,
More informationTREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD
TREATMENT OF DEPRESSION IN LATE LIFE Robert Kohn, MD WHY TREAT ELDERLY PERSONS Major depression is not a normal part of aging The rates are lower than younger cohorts The prevalence rates are still high
More informationWHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by
WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together Presented by Our agenda for today Understanding behavioral symptoms in people living with dementia Briefly review key strategies
More informationWellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion)
Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Generic name: Bupropion Available strengths: 75 mg, 100 mg immediate-release tablets; 100 mg, 150 mg, 200 mg sustained-release tablets (Wellbutrin-SR);
More informationTricyclic Antidespressants: Actions
Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs Tricyclic Antidespressants: Actions Increase sensitivity in postsynaptic alpha (α)-adrenergic, serotonin receptors Decrease sensitivity
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other BUPROPION HCL WELLBUTRIN, 01653 WELLBUTRIN SR, WELLBUTRIN XL BUPROPION HBR APLENZIN 17050 16996 26198 CITALOPRAM CELEXA 10321 GPID 16344 HYDROBROMIDE DESVENLAFAXINE
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationPresenter. Dr. Ronald Lucchino
Adverse Drug Reactions in Adults with Down Syndrome Presenter Dr. Ronald Lucchino rvluc@comcast.net PURPOSE To increase staff awareness that older adults with DD may have higher levels of medication in
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.
More information2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources
Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationZoloft (sertraline) FDA ALERT [05/2007] Suicidal Thoughts or Actions in Children and Adults
Zoloft (sertraline) FDA Alerts FDA ALERT [05/2007] Suicidal Thoughts or Actions in Children and Adults Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality)
More informationAntidepressants Choosing the Right One
Antidepressants Choosing the Right One Dr Lim Boon Leng Consultant Psychiatrist Dr BL Lim Centre For Psychological Wellness #09-09, Gleneagles Medical Centre, 6 Napier Rd, S258499 www.psywellness.com.sg
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Antidepressant Agents Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Antidepressant Agents Prime Therapeutics will review Prior Authorization requests.
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationAntidepressant Agents Step Therapy and Quantity Limit Program Summary
Antidepressant Agents Step Therapy and Quantity Limit Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-20,26,27,30,32-35,37-39,40,41,43 Drug MDD OCD PD GAD SAD PDD PTSD Bulimia Other Diagnos es Dosing
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationThe Psychopharmacology of Alzheimer s Disease. Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school
The Psychopharmacology of Alzheimer s Disease Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school Overview of Alzheimer s Disease Alzheimer s is a progressive degenerative disease Prevalence
More informationlexapro 8 Lexapro and cold symptoms Lexapro without weight gain, methadone zoloft and lexapro. 9 Is lexapro like zoloft
How long does take to wear off, help you to sleep overtime, dosage for ocd treatment, withdrawal cold sweats, social anxiety dosage. Lexapro dose for ocd, can't think straight, pros and cons of the depression
More informationAntidepressant Pharmacology An Overview
Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited
More informationPRESCRIBING DIRECTIONS FOR PSYCHOTROPIC MEDICATIONS
PRESCRIBING DIRECTIONS FOR PSYCHOTROPIC MEDICATIONS This brief information is provided to facilitate the use of these medications and is NOT intended to replace the information provided in the FDA labeling
More informationChange Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness
Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.
More informationTofranil and Tofranil-PM (imipramine)
Tofranil and Tofranil-PM (imipramine) Generic name: Imipramine Available strengths: 10 mg, 25 mg, 50 mg tablets; 75 mg, 100 mg, 125 mg, 150 mg capsules (Tofranil-PM) Available in generic: Yes Drug class:
More informationPamelor (nortriptyline)
Generic name: Nortriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg capsules; 10 mg/5 ml oral solution Available in generic: Yes Drug class: Tricyclic antidepressant General Information Pamelor
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationDiagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
More informationMajor depressive disorder (MDD) is the most prevalent. Clinical Guidelines
Clinical Guidelines Annals of Internal Medicine Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians Gerald Gartlehner, MD, MPH;
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationTreatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers
Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers By Kelsey F. Lee, PharmD candidate 2011 Preceptor: Demetra Antimisiaris, PharmD University of Louisvlle Dept. Family Medicine
More informationPharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests
Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) University of Texas Health Science Center San Antonio Pharmacotherapy Education and Research Center (PERC) 7703 Floyd Curl Drive - MSC 6220 San
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationWELLBUTRIN COMBINATIONS MONITORING PAXIL BLOOD PRESSURE BAD
WELLBUTRIN COMBINATIONS MONITORING PAXIL BLOOD PRESSURE BAD Wellbutrin Combinations Monitoring Paxil Blood Pressure Bad To add lexapro wellbutrin why Mixed with wellbutrin suboxone And wellbutrin depression
More informationRecognizing Depression and Restoring Mood and Well- Being in the Older Patient
Recognizing Depression and Restoring Mood and Well- Being in the Older Patient Andreea L. Seritan, MD UC Davis Mini Medical School February 22, 2014 Objectives Review late life depression symptoms Review
More informationAnxiety Disorders.
Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Antidepressant Agents Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Antidepressant Agents Prime Therapeutics will review Prior Authorization requests.
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2010 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationPrimary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017
John Briles, MD, Medical Director October 11, 2017 Molina Healthcare of Michigan uses a HEDIS measure for Antidepressant Medication Management (AMM) to measure how well treating providers (PCPs) appropriately
More informationAnxiety in a Headache Patient
CASE CHALLENGE Anxiety in a Headache Patient In headache patients, anxiety may increase pain while pain may fuel anxiety. Lawrence Robbins, MD Robbins Headache Clinic Northbrook, Illinois Brooke Bassett,
More informationTreating Depression in Adults
Treating Depression in Adults By Deborah Christensen, Ph.D., M.S.C.P. Depressive Disorders represent a broad and heterogeneous group of commonly diagnosed psychological disorders. The DSM adequately describes
More informationNortriptyline vs amitriptyline in elderly
Nortriptyline vs amitriptyline in elderly Amitriptyline (Elavil ) vs other antidepressants - comparative analysis amitriptyline vs divalproate, amitriptyline vs trazodone. Learn what other patients are
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More information3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview
Medications Used In the Mental Health Care of Children American Academy of Pediatrics Critical Issues in School Health March 22 nd 2018 Jennifer Zajac, D.O. Saachi Tarr, M.D. Vanessa Katon, D.O. Institute
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2012 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationVenlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:
Medication Guide VENLAFAXINE XR (venlafaxine hydrochloride) (Extended-Release Capsules) Read the Medication Guide that comes with venlafaxine hydrochloride extended-release before you start taking it and
More informationThis initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
More informationPresenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy
Depression, Anxiety, PTSD: A Focus on Pharmacotherapy Robert L Page II, Pharm.D., MSPH, FHFSA, FCCP, FAHA Professor of Clinical Pharmacy Clinical Specialist, Division of Cardiology University of Colorado
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Update: 2013 I have nothing to disclose Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California,
More information3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD
Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review
More information